New York, USA – September 29, 2021 – Acroscell, the electrophysiology platform of Creative Bioarray, focuses on providing a diverse portfolio of standard and customized drug safety & pharmacology assays and panels for drug screening and profiling. The innovative, time-efficient, cost-effective and comprehensive range of preclinical R&D services specialized in but not limited to cardiovascular & neural system physiological/pathophysiological mechanisms with strong scientific support. Recently, Acroscell announced the release of its stable cell lines for expressing ion channels.
Channelopathies are diseases caused by disturbed function of ion channel subunits or the proteins that regulate them. Ion channel mutations cause many distinct dysfunctions. Creative Bioarray has a comprehensive cell bank, a variety of professional and unique stable cell lines expressing ion channels, which can be instantly applied to a variety of in vitro studies and in vivo pharmacological studies.
With all stable cell lines or transiently expressing cells, Creative Bioarray’s electrophysiology services can provide the highest quality data to make decisions about advancing the molecule to the next stage of drug development. Creative Bioarray can provide the most reliable cell products, saving time and speeding up research. From design to delivery, all customized cell generation projects are fully managed by experienced scientists. Creative Bioarray offers a wide range of cell types including HEK293, HeLa, CHO, U2OS, etc. at a competitive price.
Based on years of cell line development experience, the cell culture scientists of Creative Bioarray focus on optimizing the parameters of all specific cell lines to efficiently produce stable cell lines according to customer requirements. Creative Bioarray provides commercial and research cell lines based on its proprietary expression vector, high-throughput cell screening technology, and serum-free and animal-free cell lines.
Creative Bioarray provides customized cell line generation, designed to meet screening needs. With more than 200 functionally verified customized cell lines, cell line generation services can be tailored to satisfy different needs, including host cell selection, constitutive or inducible expression, and customized verification which can be applied to study the pathogenesis and treatment of arrhythmia, multiple sclerosis and obesity plasma channel disease, including Andersen-Tawil syndrome, Achromatopsia and Bartter Syndrome etc.
“Creative Bioarray provides insights both for new therapies as well as understandings of diseases mechanisms, covering all your needs in electrophysiological analysis, from single-channel analysis to moving animals.” said Hannah Cole, the marketing director of Creative Bioarray, she also claimed, “We are always devoted to offering strong support in preclinical studies, accelerated drug development and improved research quality for your project.”
As a mature division of Creative Bioarray, Acroscell definitely will be the ideal and reliable innovation partner in research endeavors. With the support of professional scientists and years of experience, We are capable to provide a knowledgeable, collaborative and flexible service to our clients so as to accelerated drug development and improved research quality for worldwide projects.